Supreme Petrochem Q1 FY27 Preview: Key Benchmarks for 2026

What to watch ahead of the July 27 board meeting

Supreme Petrochem Limited (NSE: SPLPETRO) is set to consider and approve its financial results for the quarter ended June 30, 2026, at a Board of Directors meeting scheduled on July 27, 2026. The company has also scheduled an earnings conference call for July 29, 2026 at 4:00 PM IST.

With the stock in a consolidation phase into the print, investor focus is on whether Supreme Petrochem can defend margins and deliver a stable revenue trajectory amid external headwinds flagged by management. Market commentary in the provided material suggests the quarter will be judged against a clear base: the weaker Q1 FY26 profitability and the improved Q4 FY26 run-rate.

The market’s benchmark: Q1 FY26 as the baseline

The provided notes describe three main parameters the market is using to judge Supreme Petrochem, starting with an earnings benchmark tied to Q1 FY26.

For Q1 FY26 (June 2025), the company’s sales were referenced at ₹1,387 crore, with operating profit of ₹155 crore (about 8% margin as stated), and net profit of ₹81 crore. This quarter is being treated as a baseline for the upcoming Q1 FY27 print.

This matters because the same notes highlight that an earnings beat with resilient margins is being interpreted as a bullish signal, while a revenue miss combined with gross margin pressure is being treated as bearish.

Q4 FY26 recap: recovery quarter sets the near-term base

The most recent reported quarter cited in the input is Q4 FY26, with multiple representations of the same underlying numbers across formats.

Revenue from operations for Q4 FY26 was reported at ₹1,587 crore (from ₹15,870 million / ₹1,58,701.90 lakh), showing 3.12% YoY growth and 25.49% QoQ growth. Net profit for the quarter was ₹168.04 crore (from ₹1,680 million / ₹16,803.70 lakh), up 57.21% YoY.

The narrative attributes part of the Q4 recovery to styrene monomer prices remaining stable for most of the quarter. The Q4 performance is also described as reversing consecutive quarters of profit declines.

Company events and disclosures investors should track

Two dated events are explicitly mentioned and are relevant for positioning into the Q1 FY27 release:

• July 14, 2026: The company held its 37th Annual General Meeting, where a final dividend of ₹8 per share for FY26 was approved.
• July 27, 2026: Board meeting to review standalone and consolidated results for the quarter ended June 30, 2026.

Separately, historical dividend information in the input also mentions a dividend of ₹2.50 per share with a record date of Oct 31, 2025.

Capacity, utilisation and FY27 guidance checkpoints

Operationally, the input flags capacity additions and utilisation constraints that can influence volumes and operating leverage.

An EPS Phase 2 expansion was commissioned on April 14, 2026, adding 30,000 MT of capacity. Management had cautioned that FY27 volume growth guidance of 8-10% was conditional on market normalcy returning by end of June 2026.

On the ABS side, the company’s 70,000 MTPA ABS plant is stated to be operating at 65% of design capacity following a critical equipment malfunction in December 2025. The guidance-tracking list also mentions:

• Xmold utilisation target: 65-70% for FY27, tracking from a 45% base
• ABS volume target: 36,000 tons for FY27, tracking against 65% plant capacity
• Annual capex target: ₹250 crore, with H1 expenditure status to be monitored

Q1 FY27 is therefore positioned as an early checkpoint on whether the volume-growth target remains achievable under the stated condition.

Q1 FY27 estimate ranges referenced in the input

The material includes a Q1 FY27 estimate range (presented as a preview framework) and compares it to Q1 FY26 actuals.

Supreme Petrochem Q1 FY27 estimates (as cited)

• Revenue: ₹1,380-₹1,587 crore
• PAT: ₹98-₹124 crore

It also states the preview is built using Q1 FY26 base numbers of ₹1,417 crore revenue and ₹82 crore net profit, and references Q4 FY26 as the most recent growth signal.

Valuation and trading snapshots cited around late July 2026

The input provides multiple market snapshots with dates and slightly different levels, which should be read as point-in-time references.

• Relative valuation data (July 24, 2026): CMP ₹741.60, market cap ₹13,947.04 crore, P/E 42.97
• Quick details table: CMP ₹735.35, market cap ₹13,822.92 crore, previous quarter (Q4 FY26) revenue ₹1,587 crore, PAT ₹168 crore, EBITDA margin 15.95%
• Another snapshot: trading around ₹725, market cap ₹13,661 crore, P/E 41.4

The same material also references a 12-month target range of ₹723-₹817 (labelled as an estimate) and notes the stock is in a consolidation phase ahead of the results.

Technical levels and scenario map mentioned in the notes

The chart view described in the input says the price is in broader consolidation, with an asymmetrical triangle or symmetrical wedge pattern forming since early 2026.

Key levels and scenarios explicitly cited include:

• Immediate resistance: ₹750-₹760 (linked to a descending upper trend line)
• Optimistic scenario: if margins stay resilient and FY27 guidance is aggressive, target ₹950-₹982 (52-week high retest zone cited)
• Pessimistic scenario: if revenue misses and margin contraction is severe, target ₹680 (critical support retest cited)

These are presented as scenario outcomes in the source material rather than company guidance.

Key numbers table (normalised to ₹ crore)

Market impact: what changes after the print

The most immediate market sensitivity described in the input is around whether Q1 FY27 lands above or below the Q1 FY26 profit baseline and whether margins hold up. A margin defence combined with an earnings beat is framed as supportive for sentiment, while a revenue miss plus gross margin pressure is framed as negative.

Operationally, investors are likely to map commentary from management to the stated FY27 checkpoints: the conditional 8-10% volume growth guidance, utilisation improvement targets, and capex trajectory of ₹250 crore annually. The ABS plant’s operating rate of 65% after the December 2025 malfunction remains a key operational data point cited in the preview material.

Why this quarter matters in the FY27 setup

The Q1 FY27 print arrives soon after a quarter (Q4 FY26) that showed a sharp QoQ profit rebound and modest YoY revenue growth, and shortly after the EPS Phase 2 expansion commissioning in April 2026. That sequence puts more weight on management’s language around demand normalcy and supply chain conditions, which were already highlighted as a gating factor for the FY27 volume target.

Given the stock’s valuation snapshots in the low-40s P/E range cited in late July 2026, the input implies that the market is placing a premium on consistency. That makes the combination of revenue trajectory, margin stability, and clarity on utilisation improvement important variables for immediate post-results positioning.

Conclusion

Supreme Petrochem’s July 27, 2026 results review for the quarter ended June 30, 2026 will be tracked against the weaker Q1 FY26 profit base and the improved Q4 FY26 run-rate, alongside utilisation and FY27 guidance checkpoints. The next concrete event after the results will be the earnings call on July 29, 2026, where management commentary on volume growth conditions, plant utilisation, and capex should provide additional clarity.